How is COVID-19 Going to Change Medtech?

MD+DI managing editor Omar Ford discusses some of the trends that could emerge in medtech because of COVID-19.

Omar Ford

May 7, 2020

1 Min Read
How is COVID-19 Going to Change Medtech?

What’s going to happen to the industry after the COVID-19 crisis? Take a look below to see MD+DI's Managing Editor Omar Ford break down his thoughts on the matter.

 

About the Author(s)

Omar Ford

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].

 

See more from Omar Ford
Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like

Editors' Choice

Esprit BTK System
Cardiovascular
Abbott Dissolving Stent Granted Earlier-Than-Expected FDA Approval
Abbott Dissolving Stent Granted Earlier-Than-Expected FDA Approval

Apr 29, 2024

Regulatory & Quality
Philip Closes Out Recall Saga in the US
Philips Reaches Recall Settlement in the US

Apr 29, 2024

IVD
Labcorp On the Verge of Acquiring Invitae’s Assets
Labcorp Set to Acquire Invitae's Assets for $239M

Apr 29, 2024

Recent Headlines